Form 4 for CUE Cue Biopharma, Inc.
Accepted 2021-10-08 00:00:00 ET · period of report 2021-10-03 · accession 0001209191-21-060021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-08 | 2021-10-03 | CUE | Suri Anish | Pres AND CSO | M - OptEx | — | +33.3K | 108.2K | +45% | — |
| D | 2021-10-08 | 2021-10-06 | CUE | Suri Anish | Pres AND CSO | F - Tax | $12.97 | -14.1K | 94.0K | -13% | -$183.3K |
| D | 2021-10-08 | 2021-10-03 | CUE | Suri Anish | Pres AND CSO | M - OptEx | $0.00 | -33.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-03 | M | A | 33,334 | — | 108,172 | D | — | — | (F1) Represents shares of common stock received upon vesting of a restricted stock unit award. |
| 2 | Common | Common Stock | 2021-10-06 | F | D | 14,134 | $12.97 | 94,038 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-10-03 | M | D | 33,334 | $0.00 | 0 | D | — · — to — | 33,334 Common Stock | (F2) Each restricted stock unit award represents a contingent right to receive one share of common stock. (F3) On October 3, 2019, the reporting person was granted 100,000 restricted stock units, scheduled to vest in three equal annual installments beginning on October 3, 2019. |